prostate-cancer

Documents about prostate-cancer

• Adaptive Radiation Therapy for Men With Intermediate- or High-Risk Prostate Cancer#812000ClinicalTrials.gov
• A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer#839002ClinicalTrials.gov
• ED Recovery in Men Age </=65 Treated With Bilateral Nerve Sparing Robotic Assisted Prostatectomy for Prostate Cancer#842995ClinicalTrials.gov
• Characterization of Microbiological and Genetic Features in Prostate Cancer and Their Association with Disease Stage#460112ClinicalTrials.gov
• Phase II Study of DCVAC/PCa Added to Standard Chemotherapy for Men With Metastatic Castration Resistant Prostate Cancer#383574ClinicalTrials.gov
• A Phase 1 Trial of SHR3680 With or Without SHR3162 in Prostate Cancer#803294ClinicalTrials.gov
• Trial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate Cancer#837254ClinicalTrials.gov
• Testing Interruption of Hormonal Medications in Patients Responding Exceptionally to Therapy for Metastatic Prostate Cancer, (A-DREAM)#827369ClinicalTrials.gov
• MRI Guided Transurethral HIFU for Various Prostate Diseases#801232ClinicalTrials.gov
• Comparing Two Different Boost Approaches in Radiation Therapy for People With Prostate Cancer#842173ClinicalTrials.gov
• Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer#136319ClinicalTrials.gov
• Carbohydrate Restriction and Prostate Cancer Growth#810745ClinicalTrials.gov
• Safety and Efficacy of Kanglaite Gelcaps in Prostate Cancer#825420ClinicalTrials.gov
• Evaluation of Xaluritamig in High-Risk, Biochemically Recurrent, Non-metastatic Castrate-sensitive Prostate Cancer#366604ClinicalTrials.gov
• Single Arm Trial of Preoperative Stereotactic Body Radiation Therapy (SBRT) for T3a or Gleason Grade Group 4 Prostate Cancer#806312ClinicalTrials.gov
• CyberKnife® as Monotherapy or Boost SBRT for Intermediate or High Risk Localized Prostate Cancer#837353ClinicalTrials.gov
• Study of SRF617 With AB928 (Etrumadenant) and AB122 (Zimberelimab) in Patients With Metastatic Castration Resistant Prostate Cancer#152427ClinicalTrials.gov
• Vaccination Priming and Vaccine Boosting Trial of Allogeneic Human GM-CSF Gene Transduced Irradiated Prostate Cancer Cell Vaccines (GVAX® Vaccine for Prostate Cancer)#249689ClinicalTrials.gov
• Vaccine Therapy of Prostate Cancer Patients With Recombinant Soluble Prostate-Specific Membrane Antigen (Rs-PSMA) Plus the Immunological Adjuvant Alhydrogel#411260ClinicalTrials.gov
• Intratumoral Microbiota and Immune Microenvironment in Prostate Cancer#802072ClinicalTrials.gov
• Stereotactic Body Radiation Therapy in Treating Patients With Localized High-Risk Prostate Cancer#834772ClinicalTrials.gov
• GTx-758 on Serum Prostate-specific Antigen (PSA) in Men With Castrate Resistant Prostate Cancer#845865ClinicalTrials.gov
• SAKK 08/15 - PROMET - Salvage Radiotherapy +/- Metformin for Patients With Prostate Cancer After Prostatectomy#230361ClinicalTrials.gov
• Vaccine Therapy With or Without Docetaxel in Treating Patients With Metastatic Prostate Cancer#683124ClinicalTrials.gov
• PSA TOOL for Prostate Cancer Screening Discussions#828577ClinicalTrials.gov
• [18F]FLOR (FC303) PET/CT Imaging in Patients With Prostate Cancer#833202ClinicalTrials.gov
• Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation#813570ClinicalTrials.gov
• Reduction of Prostate Biopsy Morbidity#329542ClinicalTrials.gov
• Efficiency Study of Aspirin to Prevent the Occurrence of Prostate Cancer#162517ClinicalTrials.gov
• Docetaxel and Immunotherapy Prior to Prostatectomy for High-Risk Prostate Cancer#261351ClinicalTrials.gov
• Nivolumab in Prostate Cancer With DNA Repair Defects (ImmunoProst Trial)#261521ClinicalTrials.gov
• PSA Vaccine Therapy in Treating Patients With Advanced Prostate Cancer#363671ClinicalTrials.gov
• Water Vapor Ablation for Localized Intermediate Risk Prostate Cancer#802727ClinicalTrials.gov
• Tecemotide (L-BLP25) in Prostate Cancer#812441ClinicalTrials.gov
• Multimodal Telerehabilitation of Rural Patients With Advanced Prostate Cancer#812592ClinicalTrials.gov
• Prostate Cancer Risk Identification in a Multi-Ethnic Cohort: a Prospective US-based Multi-center Validation Study of Proclarix#825909ClinicalTrials.gov
• Ipilimumab and GMCSF Immunotherapy for Prostate Cancer#835667ClinicalTrials.gov
• Cell Therapy (STEAP1 CART) With Enzalutamide for the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer#356470ClinicalTrials.gov
• Vorinostat and 177Lu-PSMA-617 for the Treatment of PSMA-Low Metastatic Castration-Resistant Prostate Cancer#833472ClinicalTrials.gov
• Phase I/II Study of Immunotherapy Combination BN-Brachyury Vaccine, M7824, N-803 and Epacadostat (QuEST1)#332767ClinicalTrials.gov
• 68Ga-PSMA-11 PET/MRI for Selecting Men With Prostate Cancer for Focal Therapy#810930ClinicalTrials.gov
• Imperial Prostate 6 - Cancer Histology Artificial Intelligence Reliability Study.#805173ClinicalTrials.gov
• The Role of 68Ga-PSMA-11 PET (Prostate Specific Membrane Antigen) in Surgery Guidance in Prostate Cancer#839784ClinicalTrials.gov
• Using Fiducial Markers to Aid in Prostate Cancer Radiation Treatment#807030ClinicalTrials.gov
• Neoadjuvant ADT + Darolutamide With Pembrolizumab, Followed by Adjuvant Pembrolizumab in Molecularly Stratified High-Risk Prostate Cancer#174877ClinicalTrials.gov
• pTVG-HP DNA Vaccine With or Without pTVG-AR DNA Vaccine and Pembrolizumab in Patients With Castration-Resistant, Metastatic Prostate Cancer#234420ClinicalTrials.gov
• Clinico-pathologic Correlative Study of 3T Magnetic Resonance Spectroscopy in the Localization of Prostate Cancer#825240ClinicalTrials.gov
• Genistein in Treating Patients Undergoing External-Beam Radiation Therapy for Bone Metastases#825000ClinicalTrials.gov
• Transperineal Versus Transrectal Prostate Biopsy#180425ClinicalTrials.gov
• An Alternative to A Fixed Schedule In Management Of Prostate Cancer#143770ClinicalTrials.gov